Analysis of 11q22–q23 deletion target genes in B-cell chronic lymphocytic leukaemia: Evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B
- 31 May 2007
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (8), 1328-1335
- https://doi.org/10.1016/j.ejca.2007.02.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLLBlood, 2005
- PP2A: the expected tumor suppressorCurrent Opinion in Genetics & Development, 2005
- Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genesBlood, 2002
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancersGut, 2000
- Mantle cell lymphoma is characterized by inactivation of the ATM geneProceedings of the National Academy of Sciences of the United States of America, 2000
- Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasmsOncogene, 2000
- Somatic ATM Mutations Indicate a Pathogenic Role of ATM in B-Cell Chronic Lymphocytic LeukemiaBlood, 1999
- Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemiaThe Lancet, 1999
- Alterations of the PPP2R1B Gene in Human Lung and Colon CancerScience, 1998